Sage Therapeutics, Inc. (SAGE)

Today's Latest Price: $71.75 USD

1.89 (2.71%)

Updated Dec 4 4:00pm

Add SAGE to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Sage Therapeutics Inc (SAGE) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering SAGE.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $190 $60 $97.65 $69.86 39.78%

SAGE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.36 13 1 7 0 0 21

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The percent of analysts bearish on the stock of SAGE is lower than just about 100% of all US stocks.
  • The number of analysts covering the stock of SAGE is higher than 98.64% of stocks in the mid market cap category.
  • The variance in analysts' estimates of SAGE is less than 1.59999999999999% of stocks in the mid market cap category.
  • The average analyst price target of SAGE is greater than 90.85% of Pharmaceutical Products stocks.
  • SAGE has a higher upside potential (average analyst target price relative to current price) than 88.23% of stocks in the mid market cap category.
  • Sage Therapeutics Inc's percentage of analysts bullish on the stock is higher than 27.65% of Pharmaceutical Products stocks.
  • SAGE has a less change in bullishness amongst analysts than just about 100% of all US stocks.

Stocks similar to Sage Therapeutics Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GBT, BLUE and ALNY.

Make investment decisions regarding SAGE using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5807 seconds.